Search results
ESOPEC: FLOT Bests CROSS in Resectable Esophageal Cancer
Medscape· 3 days agoThe new findings help settle a long-standing debate and will impact disease management, but local...
Their cancers can't be cured. But new treatments are increasing the length, and quality, of their...
Milwaukee Journal Sentinel via Yahoo News· 2 days ago"He had limited options by the time he got to us," Shreenivas said. Shreenivas was able to enroll...
'Cutting the cable' between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
Medical Xpress· 5 days agoIn a study published online today in the journal Cancer Cell, researchers demonstrate that while...
S3 Episode 5: Important Advances in Small Cell Lung Cancer
Medscape· 4 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify,...
7 A-Rated Biotech Stocks Worth Betting On in June
InvestorPlace· 1 day agoLet me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance....
Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...
FOX40 Sacramento· 1 day agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Health Beat: One man’s triumph over liver disease
WFMZ Eastern Pennsylvania and Western New Jersey· 5 days agoMore than 100 million people in the U.S. are living with some form of liver disease, and some stats say that almost 80 million of them don’t even know...
'Healed on the inside': Polk man chronicles how God and family got him through cancer fight
The Ledger via Yahoo News· 2 days agoNot only was I going through cancer and trying to be a dad and a husband still, but I was trying to...
GRTS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the...
Benzinga· 21 hours agoRobbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Gritstone bio, Inc. GRTS securities between March ...
Barinthus Bio slashes headcount by 25% and refocuses pipeline
Clinical Trials Arena via Yahoo Finance· 2 days agoThe UK-based T cell specialist – formerly known as Vaccitech – said it will prioritise its pipeline...